These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 22738260)

  • 1. Beta cell response to a mixed meal in nigerian patients with type 2 diabetes.
    Young EE; Chinenye S; Unachukwu CN
    BMC Endocr Disord; 2012 Jun; 12():11. PubMed ID: 22738260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes.
    Shim WS; Kim SK; Kim HJ; Kang ES; Ahn CW; Lim SK; Lee HC; Cha BS
    Eur J Endocrinol; 2006 Oct; 155(4):615-22. PubMed ID: 16990662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
    Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
    Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated postprandial hyperglycemia in type 2 diabetic patients in a Nigerian Tertiary Health Center.
    Chinenye S; Young EE
    Indian J Endocrinol Metab; 2012 Jul; 16(4):604-8. PubMed ID: 22837924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis.
    Ketema EB; Kibret KT
    Arch Public Health; 2015; 73():43. PubMed ID: 26413295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.
    Højberg PV; Vilsbøll T; Zander M; Knop FK; Krarup T; Vølund A; Holst JJ; Madsbad S
    Diabet Med; 2008 Nov; 25(11):1268-75. PubMed ID: 19046215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.
    Gastaldelli A; Nauck MA; Balena R
    Metabolism; 2013 Sep; 62(9):1330-9. PubMed ID: 23831441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes.
    Su JB; Yang XH; Zhang XL; Cai HL; Huang HY; Zhao LH; Xu F; Chen T; Cheng XB; Wang XQ; Lu Y
    PLoS One; 2017; 12(8):e0183055. PubMed ID: 28846720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-Meal Whey Protein Alters Postprandial Insulinemia by Enhancing β-Cell Function and Reducing Insulin Clearance in T2D.
    Smith K; Taylor GS; Walker M; Brunsgaard LH; Bowden Davies KA; Stevenson EJ; West DJ
    J Clin Endocrinol Metab; 2023 Jul; 108(8):e603-e612. PubMed ID: 36734166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parameters measuring beta-cell function are only valuable in diabetic subjects with low body mass index, high blood glucose level, or long-standing diabetes.
    Lee SW; Lee S; Kim SH; Kim TH; Kang BS; Yoo SH; Lee MK; Koh WJ; Kang WS; Kim HJ
    Yonsei Med J; 2011 Nov; 52(6):939-47. PubMed ID: 22028157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naïve people with type 2 diabetes initiating basal insulin glargine 100 U/mL.
    Landgraf W; Owens DR; Frier BM; Zhang M; Bolli GB
    Diabetes Obes Metab; 2020 Mar; 22(3):315-323. PubMed ID: 31608548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients.
    Flint A; Kapitza C; Hindsberger C; Zdravkovic M
    Adv Ther; 2011 Mar; 28(3):213-26. PubMed ID: 21340616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus.
    Hovorka R; Chassin L; Luzio SD; Playle R; Owens DR
    J Clin Endocrinol Metab; 1998 Mar; 83(3):744-50. PubMed ID: 9506719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index.
    Bonadonna RC; Blonde L; Antsiferov M; Berria R; Gourdy P; Hatunic M; Mohan V; Horowitz M
    Diabetes Metab Res Rev; 2017 Sep; 33(6):. PubMed ID: 28303626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimates of the relative and absolute diurnal contributions of fasting and post-prandial plasma glucose over a range of hyperglycaemia in type 2 diabetes.
    Peter R; Dunseath G; Luzio SD; Owens DR
    Diabetes Metab; 2013 Sep; 39(4):337-42. PubMed ID: 23993831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial.
    Frías JP; Nakhle S; Ruggles JA; Zhuplatov S; Klein E; Zhou R; Strange P
    Diabetes Obes Metab; 2017 Jan; 19(1):40-48. PubMed ID: 27527911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A glimpse of the 'natural history' of established type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis.
    Coates PA; Ollerton RL; Luzio SD; Ismail I; Owens DR
    Diabetes Res Clin Pract; 1994 Dec; 26(3):177-87. PubMed ID: 7736898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial.
    Kuwata H; Iwasaki M; Shimizu S; Minami K; Maeda H; Seino S; Nakada K; Nosaka C; Murotani K; Kurose T; Seino Y; Yabe D
    Diabetologia; 2016 Mar; 59(3):453-61. PubMed ID: 26704625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.